Cargando…
Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic inflammatory disease that affects ~1% of the Caucasian population. Over the last decades, the availability of biological drugs targeting the proinflammatory cytokine tumour necrosis factor α, anti-TNF drugs, has improved the treatment of patients with RA. Howev...
Autores principales: | Bek, S, Bojesen, A B, Nielsen, J V, Sode, J, Bank, S, Vogel, U, Andersen, V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637244/ https://www.ncbi.nlm.nih.gov/pubmed/28607508 http://dx.doi.org/10.1038/tpj.2017.26 |
Ejemplares similares
-
Systematic review: genetic biomarkers associated with anti‐TNF treatment response in inflammatory bowel diseases
por: Bek, S., et al.
Publicado: (2016) -
Genetic Variations in Pattern Recognition Receptor Loci Are Associated with Anti-TNF Response in Patients with Rheumatoid Arthritis
por: Sode, Jacob, et al.
Publicado: (2015) -
Anti-TNF Treatment Response in Rheumatoid Arthritis Patients Is Associated with Genetic Variation in the NLRP3-Inflammasome
por: Sode, Jacob, et al.
Publicado: (2014) -
Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity score
por: Gilani, Syed SA, et al.
Publicado: (2020) -
Gene Polymorphisms and Pharmacogenetics in Rheumatoid Arthritis
por: Rego-Pérez, Ignacio, et al.
Publicado: (2008)